October 15, 2026
Press Release
Vividion Therapeutics Expands Clinical Development of WRN Inhibitor VVD-214 with Phase 2 Combination Study in First-Line Patients with Advanced Colorectal Cancer
September 29, 2026
Publications & Posters
Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial
September 29, 2026
Press Release
Vividion Announces Publication of Clinical Data for VVD-214 in Nature Medicine, Highlighting Potential in Colorectal Cancer
June 23, 2026
Press Release
Vividion Therapeutics Doses First Patient in Phase Ib Combination Study of WRN Inhibitor VVD-214 in Patients with Advanced Colorectal Cancer
January 6, 2026
Publications & Posters
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High Cancers
